Emi Kimoto

4.2k total citations
67 papers, 2.9k citations indexed

About

Emi Kimoto is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Emi Kimoto has authored 67 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 37 papers in Pharmacology and 24 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Emi Kimoto's work include Drug Transport and Resistance Mechanisms (43 papers), Pharmacogenetics and Drug Metabolism (30 papers) and Pharmacological Effects and Toxicity Studies (23 papers). Emi Kimoto is often cited by papers focused on Drug Transport and Resistance Mechanisms (43 papers), Pharmacogenetics and Drug Metabolism (30 papers) and Pharmacological Effects and Toxicity Studies (23 papers). Emi Kimoto collaborates with scholars based in United States, Japan and Germany. Emi Kimoto's co-authors include Manthena V. S. Varma, Yurong Lai, Yi‐An Bi, Anna Vildhede, A. David Rodrigues, Ayman El‐Kattan, Jian Lin, Hidenori Koyama, Jacek R. Wiśniewski and Per Artursson and has published in prestigious journals such as Diabetes, Analytical Biochemistry and Kidney International.

In The Last Decade

Emi Kimoto

67 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emi Kimoto United States 33 1.5k 1.1k 841 378 332 67 2.9k
Ping Zhao United States 36 1.3k 0.8× 1.1k 1.1× 682 0.8× 626 1.7× 85 0.3× 96 3.5k
Yukiya Hashimoto Japan 32 1.4k 0.9× 621 0.6× 873 1.0× 602 1.6× 135 0.4× 127 3.1k
Yvonne S. Lin United States 32 1.4k 0.9× 1.9k 1.8× 898 1.1× 849 2.2× 110 0.3× 65 4.0k
Bradley L. Urquhart Canada 26 731 0.5× 418 0.4× 397 0.5× 933 2.5× 273 0.8× 79 2.9k
Wichittra Tassaneeyakul Thailand 34 697 0.5× 1.3k 1.2× 416 0.5× 578 1.5× 153 0.5× 107 4.0k
Ikuko Yano Japan 26 907 0.6× 326 0.3× 819 1.0× 399 1.1× 113 0.3× 170 2.4k
Sophie L. Stocker Australia 28 547 0.4× 311 0.3× 448 0.5× 509 1.3× 543 1.6× 115 2.6k
Vibha Bhatnagar United States 23 700 0.5× 271 0.3× 353 0.4× 543 1.4× 350 1.1× 49 2.1k
Hirotoshi Echizen Japan 28 550 0.4× 1.2k 1.1× 337 0.4× 373 1.0× 77 0.2× 100 3.0k
Richard A. Robson New Zealand 29 388 0.3× 388 0.4× 270 0.3× 480 1.3× 348 1.0× 87 2.8k

Countries citing papers authored by Emi Kimoto

Since Specialization
Citations

This map shows the geographic impact of Emi Kimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Kimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Kimoto more than expected).

Fields of papers citing papers by Emi Kimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Kimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Kimoto. The network helps show where Emi Kimoto may publish in the future.

Co-authorship network of co-authors of Emi Kimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Kimoto. A scholar is included among the top collaborators of Emi Kimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Kimoto. Emi Kimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathialagan, Sumathy, et al.. (2025). Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug–Drug Interactions. CPT Pharmacometrics & Systems Pharmacology. 14(5). 904–917. 1 indexed citations
2.
3.
Eng, Heather, Alyssa Dantonio, Eugene P. Kadar, et al.. (2022). Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans. Drug Metabolism and Disposition. 50(5). 576–590. 77 indexed citations
4.
Costales, Chester, Jian Lin, Emi Kimoto, et al.. (2021). Quantitative prediction of breast cancer resistant protein mediated drug‐drug interactions using physiologically‐based pharmacokinetic modeling. CPT Pharmacometrics & Systems Pharmacology. 10(9). 1018–1031. 39 indexed citations
5.
Bi, Yi‐An, Chester Costales, Sumathy Mathialagan, et al.. (2019). Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 370(1). 72–83. 66 indexed citations
6.
Vildhede, Anna, Emi Kimoto, Ryan M. Pelis, A. David Rodrigues, & Manthena V. S. Varma. (2019). Quantitative Proteomics and Mechanistic Modeling of Transporter‐Mediated Disposition in Nonalcoholic Fatty Liver Disease. Clinical Pharmacology & Therapeutics. 107(5). 1128–1137. 56 indexed citations
7.
Li, Rui, Mark Niosi, Nathaniel Johnson, et al.. (2018). A Study on Pharmacokinetics of Bosentan with Systems Modeling, Part 1: Translating Systemic Plasma Concentration to Liver Exposure in Healthy Subjects. Drug Metabolism and Disposition. 46(4). 346–356. 18 indexed citations
8.
Bi, Yi‐An, Renato J. Scialis, Sarah Lazzaro, et al.. (2017). Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes. The AAPS Journal. 19(3). 787–796. 39 indexed citations
9.
Mathialagan, Sumathy, Chester Costales, Laurie Tylaska, et al.. (2017). In vitrostudies with two human organic anion transporters: OAT2 and OAT7. Xenobiotica. 48(10). 1037–1049. 20 indexed citations
10.
Kimoto, Emi, Rui Li, Renato J. Scialis, Yurong Lai, & Manthena V. S. Varma. (2015). Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide. Molecular Pharmaceutics. 12(11). 3943–3952. 33 indexed citations
11.
Li, Rui, Avijit Ghosh, Tristan S. Maurer, Emi Kimoto, & Hugh A. Barton. (2014). Physiologically Based Pharmacokinetic Prediction of Telmisartan in Human. Drug Metabolism and Disposition. 42(10). 1646–1655. 33 indexed citations
12.
Jones, Hannah M., Hugh A. Barton, Yurong Lai, et al.. (2012). Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data. Drug Metabolism and Disposition. 40(5). 1007–1017. 201 indexed citations
13.
Maurer, Tristan S., Avijit Ghosh, Nahor Haddish‐Berhane, et al.. (2011). Pharmacodynamic Model of Sodium–Glucose Transporter 2 (SGLT2) Inhibition: Implications for Quantitative Translational Pharmacology. The AAPS Journal. 13(4). 576–584. 28 indexed citations
14.
Kimoto, Emi, Robert L. Walsky, Hui Zhang, et al.. (2011). Differential Modulation of Cytochrome P450 Activity and the Effect of 1-Aminobenzotriazole on Hepatic Transport in Sandwich-Cultured Human Hepatocytes. Drug Metabolism and Disposition. 40(2). 407–411. 35 indexed citations
15.
Kimoto, Emi, et al.. (2010). Characterization of Digoxin Uptake in Sandwich-Cultured Human Hepatocytes. Drug Metabolism and Disposition. 39(1). 47–53. 38 indexed citations
16.
17.
Kimoto, Emi, Shirou Itagaki, Masaki Kobayashi, et al.. (2007). Efflux Transport of N-monodesethylamiodarone by the Human Intestinal Cell-Line Caco-2 Cells. Drug Metabolism and Pharmacokinetics. 22(4). 307–312. 11 indexed citations
18.
Fujimura, Satoshi, Katsuhisa Oshikawa, Sumio Terada, & Emi Kimoto. (2000). Primary Structure and Autoproteolysis of Brevilysin H6 from the Venom of Gloydius halys brevicaudus. The Journal of Biochemistry. 128(2). 167–173. 34 indexed citations
19.
Kawasaki, Hiroshi, et al.. (1972). Immunohistological studies on intestinal mucosaspecific glycoprotein in gastric carcinoma.. PubMed. 63(2). 231–7. 2 indexed citations
20.
Kimoto, Emi & M. R. Shetlar. (1965). Properties of Rous Sarcoma Hyaluronic Acid.. Experimental Biology and Medicine. 118(3). 627–631. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ping Zhao Breakdown of academic impact, for papers by Yukiya Hashimoto Breakdown of academic impact, for papers by Yvonne S. Lin Breakdown of academic impact, for papers by Bradley L. Urquhart Breakdown of academic impact, for papers by Wichittra Tassaneeyakul Breakdown of academic impact, for papers by Ikuko Yano Breakdown of academic impact, for papers by Sophie L. Stocker Breakdown of academic impact, for papers by Vibha Bhatnagar Breakdown of academic impact, for papers by Hirotoshi Echizen Breakdown of academic impact, for papers by Richard A. Robson
Rankless by CCL
2026